DFTX
Definium Therapeutics, Inc.
NASDAQ · USHealthcareMedical - Pharmaceuticals
$44.17-0.28%
Price as of Jul 20, 2026
DFTX ownership
Definium Therapeutics, Inc. ownership & insider activity
Latest available institutional positioning and SEC Form 4 insider transactions, coalesced at the company entity level when listings share coverage.
Insider Activity
Sentiment
0/100
Buys (3m)
0
Sells (3m)
5
Net (3m)
-$2.6M
Insider trades by month Buys Sells
Mar
Jun
Context3-month price +85.6%Institutions accumulating (13F)
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Jun 26, 2026 | Barrow Robertdirector, officer: Chief Executive Officer | Sell | 29,208 | $45.03 |
| Jun 26, 2026 | Karlin Danielofficer: Chief Medical Officer | Sell | 10,035 | $45.03 |
| Jun 26, 2026 | Wiley Matthew T.officer: Chief Commercial Officer | Sell | 2,867 | $45.03 |
| Jun 26, 2026 | Sullivan Markofficer: Chief Legal Officer | Sell | 13,008 | $45.03 |
| Jun 26, 2026 | Roberts Brandiofficer: Chief Financial Officer | Sell | 3,013 | $45.03 |
| Jun 22, 2026 | Roberts Brandiofficer: Chief Financial Officer | Grant | 62,500 | — |
| Jun 22, 2026 | Sullivan Markofficer: Chief Legal Officer | Grant | 62,500 | — |
| Jun 22, 2026 | Karlin Danielofficer: Chief Medical Officer | Grant | 100,000 | — |
| Jun 22, 2026 | Wiley Matthew T.officer: Chief Commercial Officer | Grant | 62,500 | — |
| Jun 22, 2026 | Barrow Robertdirector, officer: Chief Executive Officer | Grant | 375,000 | — |
| Jun 15, 2026 | Bruhn Suzanne Louisedirector | Grant | 4,666 | — |
| Jun 15, 2026 | Bruhn Suzanne Louisedirector | Grant | 19,188 | $24.11 |
| Jun 15, 2026 | Adsett Rogerdirector | Grant | 14,620 | $24.11 |
| Jun 15, 2026 | CRYSTAL ROGERdirector | Grant | 4,666 | — |
| Jun 15, 2026 | CRYSTAL ROGERdirector | Grant | 19,188 | $24.11 |
| Jun 15, 2026 | GRYSKA DAVID Wdirector | Grant | 4,666 | — |
| Jun 15, 2026 | GRYSKA DAVID Wdirector | Grant | 19,188 | $24.11 |
| Jun 15, 2026 | Vallone Carol Adirector | Grant | 4,666 | — |
| Jun 15, 2026 | Vallone Carol Adirector | Grant | 19,188 | $24.11 |
| Jun 15, 2026 | Krebs Andreasdirector | Grant | 4,666 | — |
| Jun 15, 2026 | Krebs Andreasdirector | Grant | 19,188 | $24.11 |
| Jun 15, 2026 | Adsett Rogerdirector | Grant | 3,555 | — |
| Mar 26, 2026 | Karlin Danielofficer: Chief Medical Officer | Sell | 8,018 | $18.47 |
| Mar 26, 2026 | Barrow Robertdirector, officer: Chief Executive Officer | Sell | 24,431 | $18.47 |
| Mar 26, 2026 | Sullivan Markofficer: Chief Legal Officer | Sell | 10,702 | $18.47 |
Source: DFTX SEC Form 4 filings, latest Jun 26, 2026. For informational purposes only — not investment advice.
Institutional activity (13F)
How institutions changed their DFTX positions over the last 6 months (SEC Form 13F).
Increased
6
New positions
252
Reduced
5
Sold out
6
Largest moves
| Institution | Action | Shares | Filed |
|---|---|---|---|
| BLACKROCK, INC. | New Position | 8.5M | May 13, 2026 |
| DRIEHAUS CAPITAL MANAGEMENT LLC | Reduced | 5.9M | May 15, 2026 |
| AVORO CAPITAL ADVISORS LLC | New Position | 5.0M | May 15, 2026 |
| JANUS HENDERSON GROUP PLC | New Position | 3.6M | May 18, 2026 |
| DEEP TRACK CAPITAL, LP | New Position | 3.0M | May 15, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | New Position | 2.5M | May 15, 2026 |
| STATE STREET CORP | New Position | 2.5M | May 15, 2026 |
| OCTAGON CAPITAL ADVISORS LP | New Position | 2.4M | May 15, 2026 |
| COMMODORE CAPITAL LP | New Position | 2.0M | May 15, 2026 |
| FMR LLC | New Position | 1.8M | May 15, 2026 |
| Trails Edge Capital Partners, LP | New Position | 1.7M | May 15, 2026 |
| GOLDMAN SACHS GROUP INC | New Position | 1.7M | May 15, 2026 |
| ARROWMARK COLORADO HOLDINGS LLC | New Position | 1.6M | May 15, 2026 |
| CITADEL ADVISORS LLC | New Position | 1.5M | May 15, 2026 |
| WELLINGTON MANAGEMENT GROUP LLP | New Position | 1.3M | May 15, 2026 |
Source: SEC Form 13F filings. For informational purposes only — not investment advice.